Company Profile
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Latest News
Oil prices sink as US-Iran pause fuels fresh Hormuz hopes
Dreame Technology Redefines Hands-free Cleaning with the Launch of the Dreame D30 Ultra Robot Vacuum
Netflix Is Down 41% in 1 Year. Could the Sell-Off Be Nearing an End?
AstraZeneca Q2 Core Earnings, Revenue Rise
The9 Names George Lai as CEO
| Sector | Healthcare |
| Industry | Health Information Services |
| Website | https://www.promed.com.au |
| Audit Risk | 1 |
| Board Risk | 8 |
| Overall Risk | 8 |
| Market Cap | 16.95B |
| Trailing P/E | 72.43 |
| Forward P/E | 90.19 |
| Dividend Rate | 0.64 |
| Dividend Yield | 0.40% |
| Trailing Annual Div. Rate | 0.62 |
| Trailing Annual Div. Yield | 0.39% |
| Trailing EPS | 2.24 |
| Forward EPS | 1.8 |
| Book Value | 3.72 |
| Price-to-Book | 43.59 |
| Enterprise-to-Revenue | 68.5 |
| Enterprise-to-EBITDA | 92.11 |
| Ex-Dividend Date | 02/26/2026 |
| Earnings Date | 08/18/2026 |
| Earnings Call Date | 08/18/2026 |